Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

References for PMC Articles for PubMed (Select 19155896)

1.

Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins.

Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, Caritis SN; Obstetric-Fetal Pharmacology Research Unit Network.

Am J Obstet Gynecol. 2007 Dec;197(6):599.e1-7.

2.

Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.

Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.

Am J Obstet Gynecol. 2007 Sep;197(3):262.e1-4.

PMID:
17826412
3.

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.

Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2007 Aug 2;357(5):454-61.

4.

Births: final data for 2004.

Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S.

Natl Vital Stat Rep. 2006 Sep 29;55(1):1-101.

5.

Infant mortality statistics from the 2003 period linked birth/infant death data set.

Mathews TJ, MacDorman MF.

Natl Vital Stat Rep. 2006 May 3;54(16):1-29.

6.

Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium.

Shynlova O, Mitchell JA, Tsampalieros A, Langille BL, Lye SJ.

Biol Reprod. 2004 Apr;70(4):986-92. Epub 2003 Nov 26.

7.
8.
9.

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2003 Jun 12;348(24):2379-85. Erratum in: N Engl J Med. 2003 Sep 25;349(13):1299.

10.

Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M.

N Engl J Med. 2000 Feb 24;342(8):534-40.

12.

Properties of the urn randomization in clinical trials.

Wei LJ, Lachin JM.

Control Clin Trials. 1988 Dec;9(4):345-64. Erratum in: Controlled Clin Trials 1989 Mar;10(1):following 126.

PMID:
3203525
13.

Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.

Reijnders FJ, Thomas CM, Doesburg WH, Rolland R, Eskes TK.

Br J Obstet Gynaecol. 1988 May;95(5):462-8.

PMID:
3135831
14.

Survival analysis in natural history studies of disease.

Cnaan A, Ryan L.

Stat Med. 1989 Oct;8(10):1255-68.

PMID:
2814073
15.

Progestogen administration in pregnancy may prevent preterm delivery.

Keirse MJ.

Br J Obstet Gynaecol. 1990 Feb;97(2):149-54.

PMID:
2138496
16.

Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor.

Johnson JW, Austin KL, Jones GS, Davis GH, King TM.

N Engl J Med. 1975 Oct 2;293(14):675-80.

PMID:
1099445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk